Edition:
India

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

48.50USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$48.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
200,037
52-wk High
$50.03
52-wk Low
$30.00

Chart for

About

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for patients with epilepsy. In... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $2,149.64
Shares Outstanding(Mil.): 50.70
Dividend: --
Yield (%): --

Financials

  SUPN.OQ Industry Sector
P/E (TTM): 21.31 30.95 32.74
EPS (TTM): 1.99 -- --
ROI: 50.40 14.84 14.38
ROE: 61.13 16.34 16.07

BRIEF-Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625 Pct Convertible Senior Notes

* SUPERNUS ANNOUNCES PRICING OF $350 MILLION PRIVATE OFFERING OF 0.625% CONVERTIBLE SENIOR NOTES

15 Mar 2018

BRIEF-Supernus Announces Proposed Private Offering Of $350 Million Of Convertible Senior Notes

* SUPERNUS ANNOUNCES PROPOSED PRIVATE OFFERING OF $350 MILLION OF CONVERTIBLE SENIOR NOTES

14 Mar 2018

BRIEF-Supernus Reports Q4 Earnings Per Share ‍$0.26​

* SUPERNUS ANNOUNCES RECORD FULL YEAR 2017 FINANCIAL RESULTS, EXCEEDING OPERATING EARNINGS GUIDANCE

28 Feb 2018

BRIEF-Supernus announces third quarter 2017 financial results

* Q3 earnings per share view $0.27 -- Thomson Reuters I/B/E/S

07 Nov 2017

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $59.19 -0.69
AstraZeneca plc (AZN.L) 4,994.00 +18.00
Eli Lilly And Co (LLY.N) $79.06 -0.69
Shire PLC (SHP.L) 3,868.00 +46.50
Shire PLC (3159084.L) -- --
Smiths Group plc (SMIN.L) 1,616.75 -1.75

Earnings vs. Estimates